Methodological approaches to evaluate the impact of FDA drug safety communications.

Author: AvornJerry, BrownsteinJohn S, CampbellEric G, Dal PanGerald J, KesselheimAaron S, LappinBrian M, RauschPaula, SchneeweissSebastian, SchwartzLisa M, SeegerJohn D, ToomeyTimothy, WoloshinSteven, ZhouEsther H

Paper Details 
Original Abstract of the Article :
When the US FDA approves a new prescription drug there is still a great deal remaining to be learned about the safe and proper use of that product. When new information addressing these topics emerges post-approval, the FDA may issue a Drug Safety Communication (DSC) to alert patients and physicians...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s40264-015-0291-y

データ提供:米国国立医学図書館(NLM)

FDA Drug Safety Communications: Evaluating Their Impact

The FDA plays a vital role in ensuring the safety and effectiveness of medications. Once a drug is approved, the FDA continues to monitor its use and issue drug safety communications (DSCs) to alert patients and healthcare professionals about new information regarding safety and efficacy. This research explores the effectiveness of these DSCs in changing patient and prescriber behavior.

Evaluating the Effectiveness of FDA Drug Safety Communications

The study examines the factors that contribute to the effectiveness of FDA DSCs. It highlights the importance of understanding how physicians and patients receive, understand, and perceive the information conveyed in these communications. The researchers emphasize the need for effective communication strategies to ensure that DSCs reach their intended audience and lead to positive changes in prescribing and patient behavior.

Navigating the Desert of Drug Safety: Clear Communication is Key

This research underscores the importance of effective communication in navigating the complex landscape of drug safety. Clear and concise communication is essential for ensuring that patients and healthcare professionals have the information they need to make informed decisions about medication use. This study provides valuable insights into the challenges and opportunities of communicating drug safety information effectively.

Dr.Camel's Conclusion

The desert of drug safety can be vast and unpredictable. This research highlights the importance of effective communication in ensuring the safety and effectiveness of medication use. By studying the factors that influence the effectiveness of FDA DSCs, we can work towards a future where drug safety information is communicated clearly and effectively, empowering patients and healthcare professionals to make informed decisions about their health.

Date :
  1. Date Completed 2016-02-23
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25968811

DOI: Digital Object Identifier

10.1007/s40264-015-0291-y

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.